Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 8/20 | 0.33 |
| ▸ | CA2 | P00918 | 8/20 | 0.33 |
| ▸ | CA9 | Q16790 | 8/20 | 0.33 |
| ▸ | CA12 | O43570 | 3/20 | 0.33 |
| ▸ | THRB | P10828 | 2/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.32 |
| ▸ | LPAR3 | Q9UBY5 | 6/20 | 0.32 |
| ▸ | LPAR2 | Q9HBW0 | 5/20 | 0.32 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.32 |
| ▸ | CA3 | P07451 | 2/20 | 0.32 |
| ▸ | CA4 | P22748 | 2/20 | 0.32 |
| ▸ | CA6 | P23280 | 2/20 | 0.32 |
| ▸ | CA5A | P35218 | 2/20 | 0.32 |
| ▸ | CA7 | P43166 | 2/20 | 0.32 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11416118 | 0.98 | THRB (0.38) | CA1CA2CA9CA12THRB | |
| SCHEMBL11208522 | 0.98 | THRB (0.38) | CA1CA2CA9CA12THRB | |
| SCHEMBL11615347 | 0.93 | THRB (0.38) | CA1CA2CA9CA12THRB | |
| SCHEMBL9329827 | 0.93 | THRB (0.38) | CA1CA2CA9CA12THRB | |
| SCHEMBL9329868 | 0.93 | THRB (0.38) | CA1CA2CA9CA12THRB | |
| SCHEMBL3899065 | 0.92 | ADRB2 (0.38) | CA1CA2TSHRHCAR2 | |
| 1-Pentanol SCHEMBL29044768 | 0.89 | SMN1; SMN2 (0.48) | CA1CA2CA9CA12THRB | |
| SCHEMBL5067425 | 0.87 | ADRB2 (0.38) | CA1CA2TSHRHCAR2 | |
| SCHEMBL9328340 | 0.87 | CA1 (0.36) | CA1CA2CA9CA12THRB | |
| SCHEMBL212058 | 0.84 | THRB (0.41) | CA1CA2CA9CA12THRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 56 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116120364-A | Preparation method of difluoro amyl phosphite | 河北圣泰材料股份有限公司 | 2023-05-16 | — | — | CN | claimed |
| US-6455665-B1 | ETHYL OR HEXYL DICHLOROPHOSPHATE OR DICHLOROPHOSPHONATE REACTED WITH A POLYESTER PREPOLYMER | GUILFORD PHARMACEUTICALS INC. | 2002-09-24 | — | — | US | claimed |
| US-20020028911-A1 | Ethyl or hexyl dichlorophosphate or dichlorophosphonate reacted with a polyester prepolymer | EISAI INC. | 2002-03-07 | — | — | US | claimed |
| WO-2002004544-A2 | POLYMERS AND POLYMERIZATION PROCESSES | GUILFORD PHARMACEUTICALS (US) | 2002-01-17 | — | — | WO | claimed |
| EP-4738516-A1 | LITHIUM SECONDARY BATTERY | SK On Co., Ltd. (KR) | 2026-05-06 | — | — | EP | disclosed |
| US-12476242-B2 | Lithium secondary battery | SK ON CO., LTD. (KR) | 2025-11-18 | — | — | US | disclosed |
| WO-2025023674-A1 | LITHIUM SECONDARY BATTERY | 에스케이온 주식회사 | 2025-01-30 | — | — | WO | disclosed |
| CN-111788732-B | Lithium secondary battery electrolyte and lithium secondary battery comprising same | SK新能源株式会社 | 2024-05-31 | — | — | CN | disclosed |
| US-20240072298-A1 | LITHIUM SECONDARY BATTERY | SK INNOVATION CO LTD (KR) | 2024-02-29 | — | — | US | disclosed |
| CN-112448012-B | Lithium secondary battery | SK新能源株式会社 | 2024-02-27 | — | — | CN | disclosed |
| US-20230393157-A1 | PHOSPHATIDYLALKANOL HOMOLOGUES HAVING LABELLED MOIETIES | CHIRON AS (NO) | 2023-12-07 | — | — | US | disclosed |
| US-11811019-B2 | Lithium secondary battery | SK ON CO., LTD. (KR) | 2023-11-07 | — | — | US | disclosed |
| US-4323503-A | PSYCHOFUNCTION PROPERTIES SUCH AS ANXIOLYTIC OR PSYCHOSTIMULANT | SOCIETE D'ETUDES SCIENTIFIQUES ET INDUSTRIELLES DE L'ILE-DE-FRANCE (FR) | 1982-04-06 | — | — | US | disclosed |
| US-4306072-A | ANXIOLYTIC AND PSYCHOSTIMULANT ACTIVITY FOR TREATMENT OF PSYCHOLOGICAL DISORDERS | SOCIETE D'ETUDES SCIENTIFIQUES ET INDUSTRIELLES DE L'ILE (FR) | 1981-12-15 | — | — | US | disclosed |
| US-4268512-A | ANXIOLYTIC AGENTS, PSYCHOSTIMULANTS | SOCIETE D'ETUDES SCIENTIFIQUES ET INDUSTRIELLES DE L'ILE-DE-FRANCE (FR) | 1981-05-19 | — | — | US | disclosed |
| US-4263316-A | ANTISPASMODIC, FOR URINARY DISORDERS | SOCIETE D'ETUDES SCIENTIFIQUES ET INDUSTRIELLES DE L'ILE DE FRANCE (FR) | 1981-04-21 | — | — | US | disclosed |
| US-4248885-A | FOR GASTROINTESTINAL, UROGENITAL, RHEUMATIC, AND CARDIOVASCULAR DISEASE | SOCIETE D'ETUDES SCIENTIFIQUES ET INDUSTRIELLES DE L'ILE-DE-FRANCE (FR) | 1981-02-03 | — | — | US | disclosed |
| US-4186135-A | TREATMENT OF PSYCHOLOGICAL DISORDERS | SOCIETE D'ETUDES SCIENTIFIQUES ET INDUSTRIELLES DE L'ILE-DE-FRANCE (FR) | 1980-01-29 | — | — | US | disclosed |
| US-4161532-A | PSYCHOLOGICAL DISORDERS, PSYCHOTROPIC | SOCIETE D'ETUDES SCIENTIFIQUES ET INDUSTRIELLES DE L'ILE DE FRANCE (FR) | 1979-07-17 | — | — | US | disclosed |
| US-4029673-A | N-(1-benzyl pyrrolidinyl 2-alkyl) substituted benzamides and derivatives thereof | SOCIETE D'ETUDES SCIENTIFIQUES ET INDUSTRIELLES DE L'ILE-DE-FRANCE (FR) | 1977-06-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230393157-A1 | PHOSPHATIDYLALKANOL HOMOLOGUES HAVING LABELLED MOIETIES | PHOSPHO1, SGMS2, SGMS1 | CA1 2946/4885CA2 4085/4885CA9 4357/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.